4,4¢,5,5¢-Tetramethyl-2,2¢-bithiazole28. M.p.: 174–175 ◦C, 1H
NMR (400 MHz, CDCl3/TMS): d 2.36 (s, 6H), 2.38 (s, 6H), 13
Acknowledgements
C
This work was financially supported by the Specialized Research
Fund for the Doctoral Program of Higher Education of China
(20060335036).
NMR (100 MHz, CDCl3/TMS): 11.5, 14.7, 128.1, 149.5, 157.0.
2,2¢-Bibenzo[d]oxazole29. M.p.: 258–259 ◦C, 1H NMR
(400 MHz, CDCl3/TMS): d 7.45–7.54 (m, 4H), 7.71 (d, J = 8.8 Hz,
2H), 7.92 (d, J = 8.0 Hz, 2H), 13C NMR (100 MHz, CDCl3/TMS):
111.4, 121.4, 125.7, 127.4, 141.1, 150.9, 151.8.
Notes and references
1 (a) Modern Carbonyl Olefination, (Ed.: T. Takeda), Wiley-VCH,
Weinheim, 2004; (b) Handbook of Metathesis, (Ed.: R. H. Grubbs),
Wiley-VCH, Weinheim, 1993, Vols. 1–3.
◦
1
5,5¢-Dimethyl-2,2¢-bibenzo[d]oxazole30. M.p.: 217–218 C, H
NMR (400 MHz, CDCl3/TMS): d 2.51 (s, 6H), 7.30 (d, J = 8.4 Hz,
2H), 7.56 (d, J = 8.4 Hz, 2H), 7.67 (s, 2H), 13C NMR (100 MHz,
CDCl3/TMS): 21.4, 110.7, 121.0, 128.6, 135.7, 141.3, 149.1, 151.9.
2 D. J. Hlasta and C. A. Zificsak, Tetrahedron, 2004, 60, 8991–9016.
3 Negishi reaction see: (a) B. A. Anderson and N. K. Harn, Synthesis,
1996, 583–585; (b) B. A. Anderson, L. M. Becke, R. N. Booher,
M. E. Flaugh, N. K. Harn, T. J. Kress, D. L. Varie and J. P. Wepsiec,
J. Org. Chem., 1997, 62, 8634–8639; (c) M. R. Reeder, H. E. Gleaves,
S. A. Hoover, R. J. Imbordino and J. J. Pangborn, Org. Process Res.
Dev., 2003, 7, 696–699; (d) E. Crowe, F. Hossner and M. J. Hughes,
Tetrahedron, 1995, 51, 8889–8900; (e) A. S. B. Prasad, T. M. Stevenson,
J. R. Citineni, V. Nyzam and P. Knochel, Tetrahedron, 1997, 53, 7237–
7254; (f) T. Bach and S. Heuser, Tetrahedron Lett., 2000, 41, 1707–1710.
4 Stille reaction see: (a) S. Sahli, B. Stump, T. Welti, W. B. Schweizer
and R. Diederich, Helv. Chim. Acta, 2005, 88, 707–730; (b) D. J.
Brauer, K. W. Kottsieper, C. Liek, O. Stelzer, H. Waffenschmidt and P.
Wasserscheid, J. Organomet. Chem., 2001, 630, 177–184; (c) I. Collins,
J. L. Castro and L. J. Street, Tetrahedron Lett., 2000, 41, 781–784;
(d) O. Krebs and R. J. K. Taylor, Org. Lett., 2005, 7, 1063–1066; (e) G.
Kennedy and A. D. Perboni, Tetrahedron Lett., 1996, 37, 7611–7614;
(f) R. Wittenberg, J. Srogl, M. Egi and L. S. Liebeskind, Org. Lett.,
2003, 5, 3033–3035.
5 Suzuki–Miyaura reaction see: (a) Y. Gong and W. He, Org. Lett., 2002,
4, 3803–3805; (b) S. Grivas and S. Lindstro¨m, J. Heterocycl. Chem.,
1995, 32, 467–471; (c) J. Ezquerra and C. Lamas, Tetrahedron, 1997, 53,
12755–12764; (d) S.-H. Lee, K. Yoshida, H. Matsushita, B. Clapham,
G. Koch, J. Zimmermann and K. D. Janda, J. Org. Chem., 2004, 69,
8829–8835; (e) B. B. Wang and P. J. Smith, Tetrahedron Lett., 2003, 44,
8967–8969; (f) K. J. Hodgetts and M. T. Kershaw, Org. Lett., 2002, 4,
1363–1365; (g) K. J. Hodgetts and M. T. Kershaw, Org. Lett., 2003, 5,
2911–2914; (h) N. Zou, J.-F. Liu and B. Jiang, J. Comb. Chem., 2003,
5, 754–755; (i) G. A. Molander and B. Biolatto, J. Org. Chem., 2003,
68, 4302–4314; (j) V. J. Majo, J. Prabhakaran, J. J. Mann and J. S. D.
Kumar, Tetrahedron Lett., 2003, 44, 8535–8537; (k) J. J. Hangeland,
A. M. Doweyko, T. Dejneka, T. J. Friends, P. Devasthale, K. Mellstro¨m,
J. Sandberg, M. Grynfarb, J. S. Sack, H. Einspahr, M. Fa¨rnegardh, B.
Husman, J. Ljunggren, K. Koehler, C. Sheppard, J. Malm and D. E.
Ryono, Bioorg. Med. Chem. Lett., 2004, 14, 3549–3553; (l) R. Pereira,
C. Gaudon, B. Iglesias, P. Germain, H. Gronemeyer and A. R. de Lera,
Bioorg. Med. Chem. Lett., 2006, 16, 49–54.
5,5¢-Diphenyl-2,2¢-bi(1,3,4-oxadiazole)31. M.p.: 269–270 ◦C,
1H NMR (400 MHz, CDCl3/TMS): d 7.57–7.66 (m, 6H), 8.24
(d, J = 7.6 Hz, 4H), 13C NMR (100 MHz, CDCl3/TMS): 122.5,
127.7, 129.3, 132.9, 153.0, 166.3.
1-Benzyl-1¢-methyl-1H,1¢H-2,2¢-bibenzo[d]imidazole. M.p.:
◦
1
176-177 C, H NMR (400 MHz, CDCl3/TMS): d 4.30 (s, 3H),
6.23 (s, 2H), 7.15–7.21 (m, 5H), 7.29–7.34 (m, 3H), 7.36–7.40 (m,
2H), 7.46 (d, J = 8.0 Hz, 1H). 7.82 (d, J = 8.4 Hz, 1H), 7.87–7.89
(m, 1H), 13C NMR (100 MHz, CDCl3/TMS): 32.4, 48.7, 110.0,
110.9, 120.3, 120.4, 122.8, 122.9, 123.9, 124.1, 127.0, 127.4, 128.6,
135.6, 136.1, 137.0, 142.4, 142.7, 143.0, 143.1. Anal. Calc. for
C22H18N4: C, 78.08; H, 5.36; N, 16.56. Found: C, 78.03; H, 5.38;
N, 16.64%
1-Benzyl-1¢-phenyl-1H,1¢H-2,2¢-bibenzo[d]imidazole. M.p.:
◦
1
186–187 C, H NMR (400 MHz, CDCl3/TMS): d 6.02 (s, 2H),
7.04–7.06 (m, 2H), 7.16–7.20 (m, 5H), 7.21–7.26 (m, 2H), 7.28–
7.36 (m, 3H), 7.38–7.41 (m, 4H), 7.63 (d, J = 7.6 Hz, 1H), 7.92
(d, J = 7.6 Hz, 1H), 13C NMR (100 MHz, CDCl3/TMS): 48.2,
110.5, 111.0, 120.4, 120.8, 122.6, 123.3, 123.9, 124.4, 126.9, 127.2,
127.6, 128.3, 128.6, 129.2, 135.3, 136.4, 136.5, 136.8, 142.5, 142.6,
142.7, 143.0. Anal. Calc. for C27H20N4: C, 80.98; H, 5.03; N, 13.99.
Found: C, 80.90; H, 5.15; N, 14.02%
2-(1-Benzyl-1H-imidazol-2-yl)-1-methyl-1H-benzo[d]imidazole.
M.p.: 89–90 ◦C, 1H NMR (400 MHz, CDCl3/TMS): 4.17 (s,
3H), 5.93 (s, 2H), 7.04 (s, 1H), 7.19–7.35 (m, 8H), 7.40 (d, J =
8.0 Hz, 1H), 7.78 (d, J = 7.2 Hz, 1H), 13C NMR (100 MHz,
CDCl3/TMS): 32.1, 51.3, 109.7, 119.9, 122.4, 122.5, 123.2, 127.7,
127.8, 128.7, 128.9, 135.9, 137.2, 137.9, 142.4, 143.6. EI-MS:
m/z = 288.
6 Stille reaction see: I. Castellote, J. J. Vaquero, J. Fernandez-Gadea and
J. Alvarez-Builla, J. Org. Chem., 2004, 69, 8668–8675.
7 Sonogashira reaction see: (a) W. M. David, D. Kumar and S. M.
Kerwin, Bioorg. Med. Chem. Lett., 2000, 10, 2509–2512; (b) A. K.
Nadipuram, W. M. David, D. Kumar and S. M. Kerwin, Org. Lett.,
2002, 4, 4543–4546; (c) J. Schlegel and G. Maas, Synthesis, 1999, 100–
106; (d) S. M. Kerwin and A. Nadipuram, Synlett, 2004, 1404–1408;
(e) N. F. Langille, L. A. Dakin and J. S. Panek, Org. Lett., 2002, 4, 2485–
2488; (f) N. D. P. Cosford, L. Tehrani, J. Roppe, E. Schweiger, N. D.
Smith, J. Anderson, L. Bristow, J. Brodkin, X. Jiang, I. Mc-Donald,
S. Rao, M. Washburn and M. A. Varney, J. Med. Chem., 2003, 46,
204–206; (g) H. Siebeneicher and S. Doye, Eur. J. Org. Chem., 2002,
1213–1220; (h) R. U. Braun and T. J. J. Mu¨ller, Tetrahedron, 2004, 60,
9463–9469.
8 H. A. Chiong and O. Daugulis, Org. Lett., 2007, 9, 1449–1451.
9 (a) B. M. Trost, Acc. Chem. Res., 2002, 35, 695–705; (b) B. M. Trost,
Angew. Chem., 1995, 107, 285–307; B. M. Trost, Angew. Chem., Int. Ed.
Engl., 1995, 34, 259–281; (c) B. M. Trost, Science, 1991, 254, 1471–1477.
10 (a) S. Havez, M. Begtrup, P. Vedsø, K. Andersen and T. Ruhland,
Synthesis, 2001, 909–913; (b) Y. Kondo, T. Komine and T. Sakamoto,
Org. Lett., 2000, 2, 3111–3113; (c) D. Sames, B. Sezen, B. S. Lane,
WO 2004 069394 [Chem. Abstr. 141:207208]; (d) C. Hoarau, A. D. de
Kerdaniel, F. N. Bracq, P. Grandclaudon, A. Couture and F. Marsais,
Tetrahedron Lett., 2005, 46, 8573–8577; (e) F. Lopez-Calahorra, M.
Martinez-Rubio, D. Velasco, E. Brillas and L. Julia, Tetrahedron,
2-◦(1-Methyl-1H-imidazol-2-yl)benzo[d]oxazole. M.p.: 140–
141 C, 1H NMR (400 MHz, CDCl3/TMS): 4.23 (s, 3H), 7.12 (s,
1H), 7.26 (s, 1H), 7.35–7.40 (m, 2H), 7.61–7.63 (m, 1H), 7.75–7.77
(m, 1H), 13C NMR (100 MHz, CDCl3/TMS): 35.6, 111.0, 120.0,
124.7, 125.2, 125.6, 130.1, 135.6, 141.5, 149.8, 154.8. EI-MS:
m/z = 199.
2-(1◦-Benzyl-1H -imidazol-2-yl)-4,5-dimethylthiazole. M.p.:
91–92 C, 1H NMR (400 MHz, CDCl3/TMS): 2.32 (s, 3H), 2.36
(s, 3H), 5.83 (s, 2H), 6.92 (s, 1H), 7.08 (s, 1H), 7.23 (d, J = 7.6 Hz,
2H), 7.26–7.32 (m, 3H), 13C NMR (100 MHz, CDCl3/TMS): 11.1,
14.8, 50.7, 122.3, 127.1, 127.72, 127.73, 128.6, 129.2, 137.1, 140.7,
148.8, 154.8. EI-MS: m/z = 269.
This journal is
The Royal Society of Chemistry 2010
Org. Biomol. Chem., 2010, 8, 326–330 | 329
©